CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Significance of Bioanalytical Studies

Significance of Bioanalytical Studies

Invenio Genetics and Imagene Labs Announces Collaboration

Invenio Genetics and Imagene Labs...

Bioanalytical Testing Services and its Market

Bioanalytical Testing Services and...

Bradford Smith, Chief Financial Officer (CFO) of Homology Medicines Joins eGenesis as an independent director

Bradford Smith, Chief Financial...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

Critical Bioanalytical Challenges of ADCs

Critical Bioanalytical Challenges of...

The Importance of Bioanalytical Method Validation

The Importance of Bioanalytical...

Korber Widens Its Werum PAS-X MES Service Partner Network

Korber Widens Its Werum PAS-X MES...

Significance of Bioanalytical Studies

Significance of Bioanalytical Studies

Invenio Genetics and Imagene Labs Announces Collaboration

Invenio Genetics and Imagene Labs...

Bioanalytical Testing Services and its Market

Bioanalytical Testing Services and...

Bradford Smith, Chief Financial Officer (CFO) of Homology Medicines Joins eGenesis as an independent director

Bradford Smith, Chief Financial...

Reducing the Energy Consumption of Ultra-Low Temperature Freezers

Reducing the Energy Consumption of...

How New Regulations are Impacting the Life Science Sector

Life Sciences Review | Thursday, December 16, 2021
Tweet

The life science sector is imposing new regulations because of the increasing cybersecurity issues.


FREMONT, CA: In addition to ensuring the safety and effectiveness of drugs, legislation in the life sciences industry seeks to ensure that innovative treatments can proceed through investigative and regulatory processes as quickly as possible. There are countless challenges, particularly as technology will continue to evolve and scientific innovations alter how drugs and devices are produced. When more devices become more complex, regulators must develop the best ways to analyze them and the fastest. Such products comprise digital pills, linked medical devices, and new molecular entities, several of which, if released to the public safely and efficiently, can enhance public health. However, continuous innovation and growth are complicated, expensive, and time-consuming, further hindered by rising safety regulations.


Medical device cybersecurity ramps up


In recent years, the scrutiny of patient data privacy has hit the tipping point, and the healthcare sector will continue to witness an advancement of cybersecurity for medical devices. More than half of providers were found to have lacked faith in the medical devices' safety, with almost one-fifth of organizations reporting malware attacks on medical devices. The FDA launched a Software Precertification Pilot Program that offers regulatory guidelines on the safety evaluation of software technologies.


The GDPR, nearer to home, has seen companies pay more attention to data security and privacy in all sectors. It meant that organizations had to protect both conventional IT systems and medical devices in the life sciences and guarantee that patient consent is obtained before gathering and processing their information. Although organizations in the life sciences may already have responded to maintain compliance with the regulations, continuous work is needed to ensure that safety is protected as technology moves ahead.


Technologies and robotics enhance regulatory activity


Robotics have made their mark in the life sciences, and it is only predicted that the use of this technology will continue to accelerate well into the future. Robotics prove their ability to perform tasks that are beyond human limits. In order to facilitate automated processes and increased regulatory supervision, next-generation technologies have been implemented, while regulators would have the power to manage more data faster, enabling them to make effective regulatory decisions. Real-time data, especially when it comes to clinical trials, can help regulators work collaboratively with the broader life sciences industry. In the near future, cloud technology, machine learning, and blockchain will have a much more significant effect on life sciences, while AI investments in the healthcare industry in 2021 is expected to hit $6.6 billion. This exponential growth of advanced technology will provide the industry with fresh regulatory challenges but represents an exciting time ahead.


Weekly Brief

loading
Top 10 Bioanalytical Service Companies in APAC - 2021
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-new-regulations-are-impacting-the-life-science-sector-nwid-218.html